Works matching IS 15989100 AND DT 2023 AND VI 21 AND IP 1

Results: 13

The impact of clinical experience on decision-making regarding the treatment and management of mild-tomoderate ulcerative colitis.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 161, doi. 10.5217/ir.2022.00006

By:

Jae Hee Cheon;
Paridaens, Kristine;
Awadhi, Sameer Al;
Begun, Jakob;
Fullarton, John R.;
Louis, Edouard;
Magro, Fernando;
Marquez, Juan Ricardo;
Moschen, Alexander R.;
Narula, Neeraj;
Rydzewska, Grazyna;
Dignass, Axel U.;
Travis, Simon P. L.

Publication type:

Article

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 137, doi. 10.5217/ir.2021.00173

By:

Kyunghwan Oh;
Hee Seung Hong;
Nam Seok Ham;
Jungbok Lee;
Sang Hyoung Park;
Suk-Kyun Yang;
Hyuk Yoon;
You Sun Kim;
Chang Hwan Choi;
Byong Duk Ye

Publication type:

Article

Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 148, doi. 10.5217/ir.2021.00168

By:

Seung Yong Shin;
Young Kim;
Won-Seok Kim;
Jung Min Moon;
Kang-Moon Lee;
Sung-Ae Jung;
Hyesook Park;
Eun Young Huh;
Byung Chang Kim;
Soo Chan Lee;
Chang Hwan Choi

Publication type:

Article

Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 126, doi. 10.5217/ir.2021.00166

By:

Kensuke Sakurai;
Takehiko Katsurada;
Mutsumi Nishida;
Satomi Omotehara;
Shinya Fukushima;
Shinsuke Otagiri;
Kazunori Nagashima;
Reizo Onishi;
Ryo Takagi;
Yoshito Komatsu;
Naoya Sakamoto

Publication type:

Article

Past, present, and future of Intestinal Research.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 1, doi. 10.5217/ir.2023.00010

By:

Jae Hee Cheon

Publication type:

Article

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 61, doi. 10.5217/ir.2022.00007

By:

Soo-Young Na;
Chang Hwan Choi;
Eun Mi Song;
Ki Bae Bang;
Sang Hyoung Park;
Eun Soo Kim;
Jae Jun Park;
Bora Keum;
Chang Kyun Lee;
Bo-In Lee;
Seung-Bum Ryoo;
Seong-Joon Koh;
Miyoung Choi;
Joo Sung Kim

Publication type:

Article

Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 3, doi. 10.5217/ir.2022.00108

By:

Han Hee Lee;
Jin Su Kim;
Hyeon Jeong Goong;
Shin Hee Lee;
Eun Hye Oh;
Jihye Park;
Min Cheol Kim;
Kwangwoo Nam;
Young Joo Yang;
Tae Jun Kim;
Seung-Joo Nam;
Hee Seok Moon;
Jae Hyun Kim;
Duk Hwan Kim;
Seong-Eun Kim;
Seong Ran Jeon;
Seung-Jae Myung

Publication type:

Article

The role and prospect of tofacitinib in patients with ulcerative colitis.

Published in:

2023

By:

Jun Lee

Publication type:

Letter to the Editor

Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 20, doi. 10.5217/ir.2022.00096

By:

Su Young Kim;
Min Seob Kwak;
Soon Man Yoon;
Yunho Jung;
Jong Wook Kim;
Sun-Jin Boo;
Eun Hye Oh;
Seong Ran Jeon;
Seung-Joo Nam;
Seon-Young Park;
Soo-Kyung Park;
Jaeyoung Chun;
Dong Hoon Baek;
Mi-Young Choi;
Suyeon Park;
Jeong-Sik Byeon;
Hyung Kil Kim;
Joo Young Cho;
Moon Sung Lee;
Oh Young Lee

Publication type:

Article

Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 43, doi. 10.5217/ir.2022.00029

By:

Seong-Joon Koh;
Sung Noh Hong;
Soo-Kyung Park;
Byong Duk Ye;
Kyeong Ok Kim;
Jeong Eun Shin;
Yong Sik Yoon;
Hong Sub Lee;
Sung Hoon Jung;
Miyoung Choi;
Soo-Young Na;
Chang Hwan Choi;
Joo Sung Kim

Publication type:

Article

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 88, doi. 10.5217/ir.2021.00154

By:

Katsuyoshi Matsuoka;
Kanae Togo;
Noritoshi Yoshii;
Masato Hoshi;
Shoko Arai

Publication type:

Article

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 110, doi. 10.5217/ir.2021.00143

By:

Toshifumi Hibi;
Satoshi Motoya;
Tadakazu Hisamatsu;
Fumihito Hirai;
Kenji Watanabe;
Katsuyoshi Matsuoka;
Masayuki Saruta;
Taku Kobayashi;
Feagan, Brian G.;
Tasset, Chantal;
Besuyen, Robin;
Chohee Yun;
Crans, Gerald;
Jie Zhang;
Akira Kondo;
Mamoru Watanabe

Publication type:

Article

Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice.

Published in:

Intestinal Research, 2023, v. 21, n. 1, p. 100, doi. 10.5217/ir.2021.00110

By:

Kun-Yu Tsai;
Jeng-Fu You;
Tzong-Yun Tsai;
Yih Jong Chern;
Yu-Jen Hsu;
Shu-Huan Huang;
Wen-Sy Tsai

Publication type:

Article